PharmiWeb.com - Global Pharma News & Resources
07-Nov-2019 - 08-Nov-2019

11th Annual NGS & Clinical Diagnostics Congress

  • Location:
    • Hammersmith International Ctre
    • 1 Shortlands
    • London
    • W6 8DR
    • United Kingdom
  • View on a map

The SynGen Series UK features 5 outstanding programmes bringing together Europe's most successful genomics experts under one roof. The series provides a networking platform which consists of key discussion topics in Next Generation Sequencing, Precision Medicine & Clinical Diagnostics Development, Single Cell Analysis, Genome Editing, Synthetic Biology for Biomedical Therapeutic Applications as well as Digital PCR Congress.

We will have over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.

Our 11th Annual Next Generation Sequencing & Clinical Diagnostics Congress will include over 90 case studies and presentations focused on the developments in NGS technologies, NGS data analysis as well as clinical applications & diagnostics of NGS.

Discover critical updates in the use of next generation sequencing and genomic technologies. Benefit from insights gained from the role of DNA sequencing on genome biology, population genetics and whole genome sequencing.

Learn more about NGS in pharma: Biomarker development, precision medicine and clinical diagnostics. Case studies include: NGS in drug discovery and development, biomarkers for precision therapies clinical genomics in immunotherapy, oncology, infectious and hereditary diseases as well as pre-natal genetic testing.

NGS and genomics in healthcare: Discuss the use of latest NGS and Genomic technologies in patient care, diagnosis and therapeutic development, clinical diagnostics development, informatics and high-throughput sequencing & profiling.

URLs:
Tickets: https://go.evvnt.com/395615-2?pid=185
Brochure: https://go.evvnt.com/395615-3?pid=185

Artists / Speakers: Patrick Descombes, Head of Functional Genomics, Senior R&D Expert, Nestlé Institute of Health Sciences, Rowena Sharpe, Head of Precision Medicine, Cancer Research UK, Atsuko Imai-Okazaki, Division Head National Center for Global Health and Medicine, Jane Wilkinson, Senior Director, Broad Genomics Alliance & Project Management, Broad Institute of MIT and Harvard University, Moritz Schütte, Lead NGS Analyst, Alacris Theranostics GmbH